CORC

在结果中检索

CORC

浏览/检索结果: 共129条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
HS016, A PROPOSED ADALIMUMAB BIOSIMILAR, SHOWED EQUIVALENT PHARMACOKINETICS AND SIMILAR SAFETY, IMMUNOGENICITY AND TOLERABILITY TO CHINA-LICENSED ADALIMUMAB IN HEALTHY MALE SUBJECTS, ACCORDING TO A 2.3-MONTHS PHASE I STUDY 会议论文
作者:  Cao, Guoying;  Yu, Jicheng;  Wang, Jingjing;  Yang, Xiaoli;  Xue, Yu
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05
A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO 会议论文
ANNALS OF THE RHEUMATIC DISEASES, 2019-06-01
作者:  Zeng, Xiaofeng;  Wang, Yongfu;  Jiang, Zhenyu;  Zhang, Zhuoli;  He, Lan
收藏  |  浏览/下载：45/0  |  提交时间：2020/01/03
EFFICACY, PHARMACOKINETICS, SAFETY AND IMMUNOGENICITY OF THE BIOSIMILAR HS016 IN COMPARISON WITH ADALIMUMAB IN CHINESE PATIENTS WITH ANKYLOSING SPONDYLITIS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PHASE 3 TRIAL 会议论文
ANNALS OF THE RHEUMATIC DISEASES, 2019-06-01
作者:  Su, Jinmei;  Li Mengtao;  Zeng, Xiaofeng
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Safety, Pharmacokinetics and Anti-Viral Efficacy of Novel Core Protein Allosteric Modifier GLS4 in Patients with Chronic Hepatitis B: Interim Results from a 48 Weeks Phase 2a Study 会议论文
作者:  Zhang, Hong;  Zhu, Xiaoxue;  Chen, Hong;  Li, Xiaojiao;  Hu, Yue
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Efficacy, safety, and pharmacokinetics of the anti-programmed cell death receptor-1 (PD-1) monoclonal antibody, tislelizumab (BGB-A317) in a phase 2, open-label, multicenter study to investigate in patients with unresectable hepatocellular carcinoma - Trial in progress 会议论文
作者:  Ren, Z.;  Assenat, E.;  Cubillo, A.;  Pluntke, S.;  Rimassa, L.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Preliminary safety, pharmacokinetics (PK) and efficacy results from a phase I study of CS1001, an anti-programmed death ligand-1 (PD-L1) monoclonal antibody (mAb) in patients (pts) with advanced tumors 会议论文
作者:  Shen, L.;  Cao, J.;  Gong, J.;  Ji, D.;  Qin, Z.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Drug-drug interactions prediction based on similarity calculation and pharmacokinetics mechanism 会议论文
作者:  Lu, Quan;  Zhang, Liangtao;  Chen, Jing;  Xu, Zeyuan
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Safety, Pharmacokinetics and Dosimetry of a Long-lasting Radiolabeled Somatostatin Analogue Lu-177-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors: A Phase 1 First-in-human Study 会议论文
JOURNAL OF NUCLEAR MEDICINE, 2018-05-01
作者:  Zhang, Jingjing;  Niu, Gang;  Wang, Hao;  Jacobson, Orit;  Cheng, Yuejuan
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
A Web-based Dashboard System for Dose Individualization of Vancomycin 会议论文
作者:  Huang, Hong;  Jiao, Zheng;  Gao, Yu-cheng;  Xie, Chen;  Gao, Jian-jun
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
INVESTIGATION INTO THE PHARMACOKINETICS AND PHARMACODYNAMICS OF SAPONINS FROM PANAX NOTOGINSENG 会议论文
作者:  Yang, Li
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace